ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1654

A Peer Health Coached Resilience-Based Energy Management Program Was Effective in Improving Fatigue and Other Outcomes in People with Systemic Sclerosis: Results of a Randomized Controlled Trial

Susan Murphy1, Yen Chen2, Mary Alore2, Sheri Hicks2, Adam Pape2, Afton Hassett2, Anna Kratz2, Daniel Whibley2, Alexandra Harper3, Suiyuan Huang2, Gina Jay2, Shannen Bolde2 and Dinesh Khanna2, 1University of Michigan, Plymouth, MI, 2University of Michigan, Ann Arbor, MI, 3University of Michigan, Ypsilanti Charter Twp, MI

Meeting: ACR Convergence 2023

Keywords: Fatigue, pain, quality of life, Randomized Trial, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: Interprofessional Exemplary

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Systemic sclerosis (SSc), a rare autoimmune condition, has a high chronic symptom burden that can have dramatic, life-altering effects on function and quality of life. Fatigue is one of the most problematic symptoms. Pain, depression, and social isolation are also potential contributors to fatigue and reduced quality of life. Our team developed a resilience-based energy management program (called RENEW) designed to be delivered through a website or app. Trained peer health coaches, who also have SSc, provided health coaching during regular online sessions over a 12-week period. This study examined whether participants in the RENEW program had clinically important improvements in fatigue, pain interference, depressive symptoms, and resilience.

Methods: In this randomized controlled trial (NCT04908943), participants were assigned to either RENEW or a wait list control group in a 2:1 ratio. Participants were ≥18 years old with doctor-diagnosed SSc of any subtype. Eligible participants had moderate to severe fatigue (≥4 on the Fatigue Severity Scale). The RENEW program included a comprehensive educational website and app with instructions for goal setting around specific topics plus 9 one-on-one health coaching sessions via Zoom over 12 weeks. The primary outcome was fatigue (assessed by PROMIS FACIT-Fatigue). Secondary outcomes were PROMIS measures of pain interference and depressive symptoms, and Connor-Davidson Resilience Scale. Outcomes were assessed at baseline, 6 weeks, and 12 weeks. Intent-to-treat linear mixed models were used to assess group differences over time, controlling for age, sex, race, SSc subtype, SSc duration, and baseline values of each outcome. A three-way interaction with group, time, and SSc duration was examined in each model.

Results: Among 173 participants (mean age 54.5 years ± 11.7), most were female (93%) and White (85%). 47% had diffuse SSc, and 57% had early SSc duration (≤5 years diagnosed) (Table 1). At 12 weeks, participants in RENEW had significantly reduced fatigue compared to controls (β=-5.1, 95% CI: -7.2 to -2.9; p < 0.001), which was considered clinically meaningful ( >3 point change). Participants also had significantly improved pain interference (β=-2.6, 95% CI -4.9 to -0.4; p = 0.021), depressive symptoms (β=-3.8, 95% CI: -6.2 to -1.5; p = 0.002), and resilience (β=2.9, 95% CI: 1.2 to 4.5; p < 0.001) compared to controls (Figures 1 & 2). Within the RENEW group, fatigue and pain at 12 weeks were found to be significantly moderated by SSc duration. Participants with ≤ 1 year SSc duration had significantly reduced fatigue compared to those with >5 year SSc duration (β=-3.1, 95% CI: -5.9 to -0.3; p = 0.032). Participants with 2-5- year SSc duration had significantly reduced pain compared to those with >5 year SSc duration (β=-4.2, 95% CI: -7.0 to -1.4; p = 0.004). No other three-way interaction effects were found.

Conclusion: A remotely-delivered, peer health coached energy management program had positive effects on fatigue and other outcomes, particularly in early diagnosed patients. This program has the potential for broad scalability to assist with SSc symptom management.

Supporting image 1

Table 1. Baseline Characteristics of the Study Participants (N = 173)

Supporting image 2

Figure 1. Fatigue and Pain Interference Change Scores by Group

Supporting image 3

Figure 2. Depressive Symptoms and Resilience Change Scores by Group


Disclosures: S. Murphy: None; Y. Chen: None; M. Alore: None; S. Hicks: None; A. Pape: None; A. Hassett: None; A. Kratz: American Psychological Association, 12, Editor, Happify/Twill, 2; D. Whibley: None; A. Harper: None; S. Huang: None; G. Jay: None; S. Bolde: None; D. Khanna: AbbVie, 12, DSMB, AstraZeneca, 2, Boehringer-Ingelheim, 2, Bristol-Myers Squibb, 2, 5, CSL Behring, 2, Genentech, 2, Horizon Therapeutics, 2, 5, Janssen, 2, 6, Pfizer, 5, Prometheus, 2.

To cite this abstract in AMA style:

Murphy S, Chen Y, Alore M, Hicks S, Pape A, Hassett A, Kratz A, Whibley D, Harper A, Huang S, Jay G, Bolde S, Khanna D. A Peer Health Coached Resilience-Based Energy Management Program Was Effective in Improving Fatigue and Other Outcomes in People with Systemic Sclerosis: Results of a Randomized Controlled Trial [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/a-peer-health-coached-resilience-based-energy-management-program-was-effective-in-improving-fatigue-and-other-outcomes-in-people-with-systemic-sclerosis-results-of-a-randomized-controlled-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-peer-health-coached-resilience-based-energy-management-program-was-effective-in-improving-fatigue-and-other-outcomes-in-people-with-systemic-sclerosis-results-of-a-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology